[Lani]

Since I often help people with rare conditions research whatever is known/being worked on, I was approached by someone with PLEIOMORPHIC lobular invasive bc that is....triple negative. That is about 1 in 10,000-1 in 1000,000 bc patients. None so far that are her2+ also.

I think the lobular vs ductal subdivision of bc based on microscopy will be considered outdated in the future as the pathways driving the cancer come to be what is important in determining prognosis and best treatment options.